• Profile
Close

Acetaminophen as a renoprotective adjunctive treatment in patients with severe and moderately severe falciparum malaria: A randomized, controlled, open-label trial

Clinical Infectious Diseases Sep 19, 2018

Plewes K, et al. - In this proof-of-principle study, researchers investigated the renoprotective effects of acetaminophen in severe malaria. They conducted this phase 2, open-label, randomized controlled trial at two hospitals in Bangladesh, randomizing 62 febrile patients (>12 years) with severe falciparum malaria to receive acetaminophen (1 g 6–hourly for 72 hours; n = 31) or no acetaminophen (n = 31), in addition to intravenous artesunate. After 72 hours, median reduction in creatinine was 23% (37% to 18%) in patients receiving acetaminophen, vs 14% (29% to 0%) in patients who didn’t. Outcomes thus suggest that acetaminophen has renoprotective effects without evidence of safety concerns in these patients, especially in those with prominent intravascular hemolysis.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay